Work

Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain

Year: 2021

Type: article

Source: Brain Behavior and Immunity

DOI: 10.1016/j.bbi.2020.12.016

Authors: Andrew J. Kwilasz, Suzanne M. Green Fulgham, Julissa Chante Duran-Malle, Anouk E.W. Schrama, Eric H. Mitten, Laurel S. Todd, Hardik P. Patel, Tracey A. Larson, Madison A. Clements, Kevin M. Harris, Scott T. Litwiler, Lewis O. Harvey, Steven F. Maier, Raymond A. Chavez, Kenner C. Rice, Anne-Marie Van Dam, Linda R. Watkins

Institutions: University of Colorado Boulder, University of Colorado System, Xalud Therapeutics (United States), National Institutes of Health, National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam

Language: English

Topic: Pain Mechanisms and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Institute of Neurological Disorders and Stroke

Award: G3226184286

OpenAlex ID: W3114865490

FWCI: 1.561

Cites: 136

Cited by: 19

Related to: 10